BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Safdar Z, Tamez E, Frost A, Guffey D, Minard CG, Entman ML. Collagen Metabolism Biomarkers and Health Related Quality of Life in Pulmonary Arterial Hypertension. Int J Cardiovasc Res 2015;4. [PMID: 26366423 DOI: 10.4172/2324-8602.1000198] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Huetsch JC, Suresh K, Bernier M, Shimoda LA. Update on novel targets and potential treatment avenues in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2016;311:L811-31. [PMID: 27591245 DOI: 10.1152/ajplung.00302.2016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
2 Chang CJ, Huang CC, Chen PR, Lai YJ. Remodeling Matrix Synthesis in a Rat Model of Aortocaval Fistula and the Cyclic Stretch: Impaction in Pulmonary Arterial Hypertension-Congenital Heart Disease. Int J Mol Sci 2020;21:E4676. [PMID: 32630068 DOI: 10.3390/ijms21134676] [Reference Citation Analysis]
3 Wilkins M. Pulmonary hypertension: Proteins in the blood. Glob Cardiol Sci Pract 2020;2020:e202007. [PMID: 33178814 DOI: 10.21542/gcsp.2020.7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Kobayashi T, Tomofuji T, Machida T, Yoneda T, Ekuni D, Azuma T, Maruyama T, Hirose A, Morita M. Expression of Salivary miR-203a-3p Was Related with Oral Health-Related Quality of Life in Healthy Volunteers. Int J Mol Sci 2017;18:E1263. [PMID: 28608821 DOI: 10.3390/ijms18061263] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
5 Wang X, Lin L, Chai X, Wu Y, Li Y, Liu X. Hypoxic mast cells accelerate the proliferation, collagen accumulation and phenotypic alteration of human lung fibroblasts. Int J Mol Med 2020;45:175-85. [PMID: 31746371 DOI: 10.3892/ijmm.2019.4400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Safdar Z, Cho E. Effect of spironolactone use in pulmonary arterial hypertension - analysis from pivotal trial databases. Pulm Circ 2021;11:20458940211045618. [PMID: 34790347 DOI: 10.1177/20458940211045618] [Reference Citation Analysis]
7 Franz M, Grün K, Betge S, Rohm I, Ndongson-Dongmo B, Bauer R, Schulze PC, Lichtenauer M, Petersen I, Neri D, Berndt A, Jung C. Lung tissue remodelling in MCT-induced pulmonary hypertension: a proposal for a novel scoring system and changes in extracellular matrix and fibrosis associated gene expression. Oncotarget 2016;7:81241-54. [PMID: 27835899 DOI: 10.18632/oncotarget.13220] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
8 Pang W, Zhang Z, Zhang Y, Zhang M, Miao R, Yang Y, Xie W, Wan J, Zhai Z, Wang C. Extracellular matrix collagen biomarkers levels in patients with chronic thromboembolic pulmonary hypertension. J Thromb Thrombolysis 2021;52:48-58. [PMID: 33175289 DOI: 10.1007/s11239-020-02329-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]